Across TCGA pan-cancer cohorts, BAZ1A mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated BAZ1A data layer compared with 25 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher BAZ1A mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated BAZ1A expression acts as an unfavorable survival marker, although some lineages such as LSCC and UCEC show a favorable association.

LSCC, PDAC, and UCEC are the cancer types where BAZ1A mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	DFS	Median	II,III,IV	0.886	0.517	.001	29	view →
PDAC	OS	Quartile	All	0.679	0.964	.001	25	view →
UCEC	DFS	Tertile	III,IV	1.000	0.289	.008	12	view →
LUAD	DFS	Tertile	II,III,IV	0.933	0.655	.026	8	view →
CCRCC	DFS	Median	II,III,IV	0.771	0.478	.008	5	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: BAZ1A tumor-vs-normal RNA expression · all BAZ1A data types